Product
Supplier
Encyclopedia
Inquiry
Home > News > Company Dynamic > EU Approves AstraZeneca's COVID-19 Vaccine Vaxzevria as Adult Booster

EU Approves AstraZeneca's COVID-19 Vaccine Vaxzevria as Adult Booster

ECHEMI 2022-05-23

On May 23, AstraZeneca said its new crown vaccine Vaxzevria had been approved by the European Medicines Agency (EMA) as a booster vaccine for adults. Last Thursday, AstraZeneca's new crown vaccine booster (clinical trial data) received a positive assessment from the CHMP (European Committee for Medicinal Products for Human Use).

It is reported that the vaccine can be used as a booster for the first two doses of the Vaxzevria new crown vaccine, and can also be used as a booster for other mRNA new crown vaccines produced by companies such as Pfizer (PFE.US)/BioNTech (BNTX.US) or Moderna (MRNA.US). Strengthen the needle.

Disclaimer: ECHEMI reserves the right of final explanation and revision for all the information.
Company-Dynamic
Comment
Comment

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.